These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23568001)

  • 1. Long-term risk perceptions of women with ductal carcinoma in situ.
    Ruddy KJ; Meyer ME; Giobbie-Hurder A; Emmons KM; Weeks JC; Winer EP; Partridge AH
    Oncologist; 2013; 18(4):362-8. PubMed ID: 23568001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
    Partridge A; Adloff K; Blood E; Dees EC; Kaelin C; Golshan M; Ligibel J; de Moor JS; Weeks J; Emmons K; Winer E
    J Natl Cancer Inst; 2008 Feb; 100(4):243-51. PubMed ID: 18270338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
    Sanders ME; Schuyler PA; Dupont WD; Page DL
    Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
    Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
    Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
    Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L
    Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.
    Liu Y; Pérez M; Schootman M; Aft RL; Gillanders WE; Ellis MJ; Jeffe DB
    Breast Cancer Res Treat; 2010 Dec; 124(3):835-44. PubMed ID: 20446031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study.
    Strell C; Smith DR; Valachis A; Woldeyesus H; Wadsten C; Micke P; Fredriksson I; Schiza A
    Breast Cancer Res Treat; 2024 Sep; 207(2):293-299. PubMed ID: 38763971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
    Solin LJ; Gray R; Hughes LL; Wood WC; Lowen MA; Badve SS; Baehner FL; Ingle JN; Perez EA; Recht A; Sparano JA; Davidson NE
    J Clin Oncol; 2015 Nov; 33(33):3938-44. PubMed ID: 26371148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ of the breast - Long term results from a twenty-year cohort.
    Co M; Kwong A
    Cancer Treat Res Commun; 2018; 14():17-20. PubMed ID: 30104003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
    Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
    J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
    Van Bockstal MR; Agahozo MC; Koppert LB; van Deurzen CHM
    Int J Cancer; 2020 Mar; 146(5):1189-1197. PubMed ID: 31018242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma
    Visser LL; Elshof LE; Schaapveld M; van de Vijver K; Groen EJ; Almekinders MM; Bierman C; van Leeuwen FE; Rutgers EJ; Schmidt MK; Lips EH; Wesseling J
    Clin Cancer Res; 2018 Aug; 24(15):3593-3601. PubMed ID: 29685879
    [No Abstract]   [Full Text] [Related]  

  • 14. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
    van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
    Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
    Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
    Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community.
    Hassett MJ; Jiang W; Habel LA; Nekhlyudov L; Achacoso N; Acton L; Schnitt SJ; Schrag D; Punglia RS
    Breast Cancer Res Treat; 2016 Feb; 155(3):541-9. PubMed ID: 26843057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.
    Punglia RS; Jiang W; Lipsitz SR; Hughes ME; Schnitt SJ; Hassett MJ; Nekhlyudov L; Achacoso N; Edge S; Javid SH; Niland JC; Theriault RL; Wong YN; Habel LA
    Breast Cancer Res Treat; 2018 Feb; 167(3):751-759. PubMed ID: 29079937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-receptor status and risk of contralateral breast cancer following DCIS.
    Stout NK; Cronin AM; Uno H; Ozanne EM; Hassett MJ; Frank ES; Greenberg CC; Punglia RS
    Breast Cancer Res Treat; 2018 Oct; 171(3):777-781. PubMed ID: 29946862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS.
    Nekhlyudov L; Habel LA; Achacoso N; Jung I; Haque R; Collins LC; Schnitt SJ; Quesenberry CP; Fletcher SW
    J Natl Cancer Inst; 2012 Apr; 104(8):614-21. PubMed ID: 22491230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?].
    André G; Tunon-de-Lara C; Macgrogan G; Laharie-Mineur H; Bussieres JE; Valentin F; Barreau B; Dilhuydy MH; Dilhuydy JM; Mauriac L; Debled M; Durand M; Mathoulin S; Avril A
    J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):260-6. PubMed ID: 17376610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.